The estimated Net Worth of Bruce D Perkins is at least $4.95 Million dollars as of 1 September 2021. Mr. Perkins owns over 11,511 units of Amedisys stock worth over $1,728,290 and over the last 12 years he sold AMED stock worth over $2,947,743. In addition, he makes $271,089 as Independent Director at Amedisys.
Sign up
Mr. Perkins AMED stock SEC Form 4 insiders trading
Bruce has made over 13 trades of the Amedisys stock since 2013, according to the Form 4 filled with the SEC. Most recently he sold 11,511 units of AMED stock worth $2,106,513 on 1 September 2021.
The largest trade he's ever made was selling 11,511 units of Amedisys stock on 1 September 2021 worth over $2,106,513. On average, Bruce trades about 1,394 units every 89 days since 2012. As of 1 September 2021 he still owns at least 17,869 units of Amedisys stock.
You can see the complete history of Mr. Perkins stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Bruce Perkins biography
Bruce D. Perkins serves as Independent Director of the Company. He is currently the managing member for Perkins, Smith & Associates, L.L.C. (“PSA”), a healthcare consulting firm based in Louisville, Kentucky. He also serves on the boards of three private companies: Advanced Dermatology and Cosmetic Surgery; Physician’s Endoscopy; and Remedi SeniorCare. Additionally, Mr. Perkins serves as a strategic executive for myNEXUS; a strategic advisor and executive coach for ChenMed; a senior advisor for the Marwood Group; a senior advisor for US Imaging; a consultant for Devoted Health and a consultant for Magellan Health, Inc. Previously, Mr. Perkins served as a board member of Athletico, LHP Hospital Group, Humana Health Plan of Puerto Rico, and was chairman of the board of MCCI Group Holdings. From 2015 to 2019, Mr. Perkins held the role of Strategic Executive and Advisor to the Chairman and CEO of MCCI Group Holdings and its successor, Conviva Health Solutions. Mr. Perkins retired from Humana Inc. in 2014 after a thirty-eight-year career. Prior to retirement, he was the President of Healthcare Services, a $21 billion business segment which included pharmacy, home care, behavioral health, physician services, provider networks, provider administration, and clinical platforms. Before Mr. Perkins became President of Healthcare Services, he served as Regional Vice President and Divisional President for Humana health plans. Prior to Humana’s spin-off of its hospital business, Mr. Perkins held multiple hospital leadership positions including Divisional Vice President and Hospital CEO, COO, and CFO. Director Qualifications: Extensive Knowledge of the Healthcare Industry—Mr. Perkins has over 43 years of experience in the healthcare industry. Relevant Executive/Leadership Experience—Mr. Perkins is the managing member for Perkins, Smith, & Associates, L.L.C., a private healthcare consulting company, and previously served as the President of Humana’s Healthcare Services Segment, which had annual revenue of $21 billion.
What is the salary of Bruce Perkins?
As the Independent Director of Amedisys, the total compensation of Bruce Perkins at Amedisys is $271,089. There are 13 executives at Amedisys getting paid more, with Paul Kusserow having the highest compensation of $12,835,500.
How old is Bruce Perkins?
Bruce Perkins is 66, he's been the Independent Director of Amedisys since 2015. There are 1 older and 19 younger executives at Amedisys. The oldest executive at Amedisys Inc. is Molly Coye, 72, who is the Independent Director.
What's Bruce Perkins's mailing address?
Bruce's mailing address filed with the SEC is 3854 AMERICAN WAY, SUITE A, , BATON ROUGE, LA, 70816.
Insiders trading at Amedisys
Over the last 27 years, insiders at Amedisys have traded over $269,564,877 worth of Amedisys stock and bought 2,690,968 units worth $38,198,016 . The most active insiders traders include Asset Management Llc Kohlbe..., Tide Capital, Llc North Tid..., and David Nierenberg. On average, Amedisys executives and independent directors trade stock every 29 days with the average trade being worth of $2,494,602. The most recent stock trade was executed by Richard M Ashworth on 26 December 2023, trading 11,237 units of AMED stock currently worth $896,937.
What does Amedisys do?
amedisys is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients across the country to age in place. from home health to hospice to personal care, amedisys team members provide quality, clinically-distinctive care to more than 376,000 patients every year. every life is precious and tells an incredible story, and we celebrate that each day by honoring our patients with genuine, personal attention. everything we do, from the boardroom to our nationwide network of care centers, is centered on the best care possible for those who have entrusted us with their well-being and comfort. we work closely with doctors and other healthcare providers to coordinate services, and every patient has an individual plan of care that meets their specific needs. amedisys recognizes that nothing we do is possible without our incredible team. for all employees, whether they’re on the front lines delivering direct care or supporting our clinical team, this i
What does Amedisys's logo look like?
Complete history of Mr. Perkins stock trades at Amedisys and Humana
Amedisys executives and stock owners
Amedisys executives and other stock owners filed with the SEC include:
-
Paul Kusserow,
Chairman of the Board, President, Chief Executive Officer -
Christopher Gerard,
Chief Operating Officer -
Scott Ginn,
Chief Financial Officer -
Sharon Brunecz,
Chief Human Resource Officer -
David Kemmerly,
Chief Legal and Government Affairs Officer -
Paul Berthold Kusserow,
Chairman & CEO -
Michael North,
Chief Information Officer -
Christopher T. Gerard,
Pres, COO & Director -
Scott G. Ginn,
Exec. VP & CFO -
David L. Kemmerly,
Chief Legal & Gov. Affairs Officer -
Sharon Brunecz,
Chief HR Officer -
Julie Klapstein,
Independent Director -
Richard Lechleiter,
Lead Independent Director -
Bruce Perkins,
Independent Director -
Jeffrey Rideout,
Independent Director -
Teresa Kline,
Independent Director -
Molly Coye,
Independent Director -
Vickie Capps,
Independent Director -
Nick Muscato,
Vice President of Strategic Finance -
Denise Bohnert,
Chief Compliance Officer -
Janet Britt,
Sr. VP of Billing & Collections -
Adam Holton,
Chief People Officer -
Jennifer Guckert Griffin,
Sr. VP, Deputy Gen. Counsel, Corp. Sec. & Interim Chief Legal Officer -
John Nugent,
Chief Acquisitions Officer -
Kendra Kimmons,
VP of Marketing & Communications -
Denise Bohnert,
Chief Compliance Officer -
Michael P. North,
Chief Information Officer -
Pete Hartley,
CTO & Sr. VP of Bus. Operations Systems -
Jake L Netterville,
Director -
Jeffrey D Jeter,
Chief Compliance Officer -
Donald A Washburn,
Director -
Nathaniel M Zilkha,
Director -
David B. Pearce,
Chief Compliance Officer -
Lawrence R Pernosky,
Chief Human Resources Officer -
Martin B Howard,
Chief Information Officer -
Ronald A Laborde,
Director -
Stephen Seim,
Chief Strategy Officer -
Gary D Willis,
Chief Financial Officer -
Linda J. Hall,
Director -
Jane Carmody,
See Remarks -
Daniel P Mc Coy,
Chief Operating Officer -
Alice A Schwartz,
CIO -
Susan Sender,
See Remarks -
Asset Management Llc Kohlbe...,
-
Allyson Guidroz,
Chief Accounting Officer -
Richard M Ashworth,
President and CEO -
Larry R Graham,
COO -
Donald Jr Loverich,
Principal Accounting Officer -
John F Giblin,
Chief Financial Officer -
Gregory H Browne,
Chief Financial Officer -
David Nierenberg,
10% owner -
John Hank Linden,
Chief Information Officer -
Listed Ltd Terra,
10% owner -
Tide Capital, Llc North Tid...,
-
Peter Ricchiuti,
Director -
Michael O. Fleming,
Chief Medical Officer -
David R Bucey,
General Counsel and Secretary -
David R Pitts,
Director -
William F Borne,
CEO -
T A Jr Barfield,
Chief Development Officer -
Dale E Redman,
Chief Financial Officer -
Michael D Snow,
Chief Operating Officer -
Ivanetta Davis Samuels,
Director -
Adam Y Holton,
Chief People Officer